Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles

被引：6
作者：
Lin, Hung-Yao [1 ]
Tseng, Tai-Chung [1 ,2 ,3 ]
机构：
[1] Natl Taiwan Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Hepatitis Res Ctr, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Med Res, 1 Chang Te St, Taipei 10002, Taiwan
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2022年 / 28卷 / 02期
关键词：
Tenofovir disoproxil fumarate; Tenofovir alafenamide; Hyperlipidemias; Tenofovir;
D O I：
10.3350/cmh.2022.0028
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：181 / 182
页数：2
相关论文
共 50 条
  • [41] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Hye Won Lee
    Young Youn Cho
    Hyein Lee
    Jae Seung Lee
    Seung Up Kim
    Jun Yong Park
    Do Young Kim
    Sang Hoon Ahn
    Beom Kyung Kim
    Soo Young Park
    Hepatology International, 2021, 15 : 1083 - 1092
  • [42] Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide
    Fong, Tse-Ling
    Lee, Brian T.
    Tien, Andy
    Chang, Mimi
    Lim, Carolina
    Ahn, Alden
    Bae, Ho S.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (05) : 561 - 567
  • [43] Switching from entecavir to tenofovir alafenamide versus maintaining entecavir for chronic hepatitis B
    Hagiwara, Satoru .
    Nishida, Naoshi
    Ida, Hiroshi
    Ueshima, Kazuomi
    Minami, Yasunori
    Takita, Masahiro
    Komeda, Yoriaki
    Kudo, Masatoshi
    JOURNAL OF MEDICAL VIROLOGY, 2019, 91 (10) : 1804 - 1810
  • [44] Chronic Hepatitis B Relapse Rates after Cessation of Tenofovir Alafenamide and Entecavir Therapy
    Huang, Chih-Wen
    Yang, Chen-Ta
    Su, Pei-Yuan
    Chen, Yang-Yuan
    Huang, Siou-Ping
    Yen, Hsu-Heng
    BIOMEDICINES, 2023, 11 (03)
  • [45] Comparison of Pegylated Interferon Alfa Therapy in Combination with Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate for Treatment of Chronic Hepatitis B Patients
    He, Jingjing
    Guo, Yifei
    Zhang, Yao
    Han, Jiajia
    Chen, Jingwen
    Jia, Yidi
    Ma, Zhenxuan
    Wu, Jingwen
    Zhang, Shenyan
    Li, Fahong
    Mao, Richeng
    Zhang, Jiming
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 3929 - 3941
  • [46] Impact of Tenofovir Alafenamide on Lipid Profiles in Chronic Hepatitis B Patients: Systematic Review and Meta-Analysis
    Hsu, Ping-Yu
    Su, Hui-Chen
    Ma, Mi-Chia
    Chen, Chien-An
    Yu, Sin-Yi
    Hua, Yi-Ming
    JOURNAL OF MEDICAL VIROLOGY, 2025, 97 (04)
  • [47] Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide
    Yeh, Ming-Lun
    Liang, Po-Cheng
    Trinh, Sam
    Huang, Ching-, I
    Huang, Chung-Feng
    Hsieh, Ming -Yen
    Huang, Jee-Fu
    Dai, Chia-Yen
    Chuang, Wan-Long
    Nguyen, Mindie H.
    Yu, Ming-Lung
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (07) : 1273 - 1282
  • [48] Cost-Utility Analysis of Tenofovir Alafenamide and Entecavir in Chronic Hepatitis B Patients: A Markov Decision Model
    Lai, Chun-Huang
    Shi, Hon-Yi
    Tsai, Cheng-En
    Yang, Yuan-Chieh
    Chiu, Si-Un Frank
    CANCERS, 2024, 16 (04)
  • [49] Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B
    Itokawa, Norio
    Atsukawa, Masanori
    Tsubota, Akihito
    Takaguchi, Koichi
    Nakamuta, Makoto
    Hiraoka, Atsushi
    Kato, Keizo
    Abe, Hiroshi
    Mikami, Shigeru
    Shimada, Noritomo
    Chuma, Makoto
    Akito, Nozaki
    Uojima, Haruki
    Ogawa, Chikara
    Asano, Toru
    Tani, Joji
    Morishita, Asahiro
    Senoh, Tomonori
    Yamashita, Naoki
    Oikawa, Tsunekazu
    Matsumoto, Yoshihiro
    Koeda, Mai
    Yoshida, Yuji
    Tanabe, Tomohide
    Okubo, Tomomi
    Arai, Taeang
    Hayama, Korenobu
    Iwashita, Ai-Nakagawa
    Kondo, Chisa
    Tada, Toshifumi
    Toyoda, Hidenori
    Kumada, Takashi
    Iwakiri, Katsuhiko
    JGH OPEN, 2021, 5 (01): : 34 - 40
  • [50] Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B
    Kim, Tae Hyung
    Kim, Ji Hoon
    Yim, Hyung Joon
    Seo, Yeon Seok
    Yim, Sun Young
    Lee, Young-Sun
    Jung, Young Kul
    Yeon, Jong Eun
    Um, Soon Ho
    Byun, Kwan Soo
    GUT AND LIVER, 2024, 18 (02) : 305 - 315
12345